Global Prothrombin Time Testing Market Growth (Status and Outlook) 2025-2031

According to this study, the global Prothrombin Time Testing market size will reach US$ million by 2031.

Prothrombin time (PT) is a blood test which is used to assess the time required to clot a blood. This test is useful to detect and diagnose various bleeding and excessive clotting disorder and also used to monitor the efficacy of various anticoagulant.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

LPI (LP Information)' newest research report, the “Prothrombin Time Testing Industry Forecast” looks at past sales and reviews total world Prothrombin Time Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Prothrombin Time Testing sales for 2025 through 2031. With Prothrombin Time Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prothrombin Time Testing industry.

This Insight Report provides a comprehensive analysis of the global Prothrombin Time Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Prothrombin Time Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prothrombin Time Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prothrombin Time Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prothrombin Time Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Prothrombin Time Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Mechanical Technology Testing
Electrochemical Technology Testing
Optical Technology Testing
Others

Segmentation by Application:
Hospital
Home Care Setting
Diagnostics Laboratory
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Nihon Kohden
Sekisui Chemical
Universal Biosensors
Roche
Sysmex
Medtronic
Micropoint Biosciences
Danaher
Chrono-log
Thermo Fisher Scientific
Abbott
Helena Laboratories
Siemens

Please note: The report will take approximately 2 business days to prepare and deliver. Show more